Correlation Between Regencell Bioscience and ANI Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Regencell Bioscience and ANI Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regencell Bioscience and ANI Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regencell Bioscience Holdings and ANI Pharmaceuticals, you can compare the effects of market volatilities on Regencell Bioscience and ANI Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regencell Bioscience with a short position of ANI Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regencell Bioscience and ANI Pharmaceuticals.
Diversification Opportunities for Regencell Bioscience and ANI Pharmaceuticals
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Regencell and ANI is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Regencell Bioscience Holdings and ANI Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ANI Pharmaceuticals and Regencell Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regencell Bioscience Holdings are associated (or correlated) with ANI Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ANI Pharmaceuticals has no effect on the direction of Regencell Bioscience i.e., Regencell Bioscience and ANI Pharmaceuticals go up and down completely randomly.
Pair Corralation between Regencell Bioscience and ANI Pharmaceuticals
Considering the 90-day investment horizon Regencell Bioscience Holdings is expected to generate 5.04 times more return on investment than ANI Pharmaceuticals. However, Regencell Bioscience is 5.04 times more volatile than ANI Pharmaceuticals. It trades about 0.11 of its potential returns per unit of risk. ANI Pharmaceuticals is currently generating about -0.11 per unit of risk. If you would invest 483.00 in Regencell Bioscience Holdings on August 24, 2024 and sell it today you would earn a total of 82.00 from holding Regencell Bioscience Holdings or generate 16.98% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Regencell Bioscience Holdings vs. ANI Pharmaceuticals
Performance |
| Timeline |
| Regencell Bioscience |
| ANI Pharmaceuticals |
Regencell Bioscience and ANI Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Regencell Bioscience and ANI Pharmaceuticals
The main advantage of trading using opposite Regencell Bioscience and ANI Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regencell Bioscience position performs unexpectedly, ANI Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will offset losses from the drop in ANI Pharmaceuticals' long position.| Regencell Bioscience vs. Catalent | Regencell Bioscience vs. Amphastar P | Regencell Bioscience vs. ANI Pharmaceuticals | Regencell Bioscience vs. Alkermes Plc |
| ANI Pharmaceuticals vs. Phibro Animal Health | ANI Pharmaceuticals vs. Prestige Brand Holdings | ANI Pharmaceuticals vs. Alkermes Plc | ANI Pharmaceuticals vs. Dr Reddys Laboratories |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |